Semaglutide May Reduce Alcohol Use Disorder, Lancet Study Finds 8 May 2026·721 words·4 mins Semaglutide Alcohol Use Disorder GLP-1 Obesity Clinical Trial The Lancet Addiction Medicine Metabolic Health
